Comparison of patients with and without new tachyarrhythmias
Comparison of patients with new tachyarrhythmias with the no arrhythmias
group (Supplementry Table 1) shows that patients with new
tachyarrhythmias (n=25, 6.4%) were older, had more comorbidities, and
experienced a more severe disease. Rate of respiratory symptoms was
higher among patients with new tachyarrhythmias, however it was not
statistically significant (p=0.07). As expected, more patients with new
tachyarrhythmias received a QT prolonging drug which included mainly
anti-arrhythmic medications. Differences in other ECG and laboratory
results are further described in Supplementary table 1.